CHESSA, ELISABETTA
 Distribuzione geografica
Continente #
EU - Europa 34.547
NA - Nord America 2.808
AS - Asia 1.394
SA - Sud America 199
Continente sconosciuto - Info sul continente non disponibili 193
AF - Africa 35
OC - Oceania 4
Totale 39.180
Nazione #
IT - Italia 33.985
US - Stati Uniti d'America 2.723
SG - Singapore 550
CN - Cina 357
VN - Vietnam 148
BR - Brasile 146
SE - Svezia 117
DE - Germania 99
FI - Finlandia 94
FR - Francia 59
GB - Regno Unito 55
HK - Hong Kong 52
CA - Canada 48
IN - India 43
JP - Giappone 36
BD - Bangladesh 32
TR - Turchia 32
IQ - Iraq 29
ES - Italia 25
KR - Corea 21
NL - Olanda 21
UA - Ucraina 21
EC - Ecuador 12
IR - Iran 12
MX - Messico 12
PK - Pakistan 12
AR - Argentina 11
AT - Austria 11
PL - Polonia 11
CL - Cile 10
ID - Indonesia 10
EG - Egitto 9
UZ - Uzbekistan 9
IE - Irlanda 8
JM - Giamaica 8
ZA - Sudafrica 8
GR - Grecia 7
CO - Colombia 6
CZ - Repubblica Ceca 6
PH - Filippine 6
RU - Federazione Russa 6
AZ - Azerbaigian 5
MA - Marocco 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
JO - Giordania 4
PE - Perù 4
PS - Palestinian Territory 4
SA - Arabia Saudita 4
TW - Taiwan 4
VE - Venezuela 4
AL - Albania 3
CR - Costa Rica 3
DZ - Algeria 3
LT - Lituania 3
NI - Nicaragua 3
PA - Panama 3
PY - Paraguay 3
RO - Romania 3
TN - Tunisia 3
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
DK - Danimarca 2
ET - Etiopia 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
MY - Malesia 2
OM - Oman 2
PT - Portogallo 2
SN - Senegal 2
BG - Bulgaria 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
KE - Kenya 1
KH - Cambogia 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
NO - Norvegia 1
NP - Nepal 1
PR - Porto Rico 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 38.988
Città #
Cagliari 32.354
Uta 1.344
Ashburn 360
Dallas 334
Singapore 328
San Jose 207
Boardman 120
Fairfield 105
Council Bluffs 97
New York 81
Helsinki 80
Chandler 68
Beijing 67
Los Angeles 63
Santa Clara 58
Woodbridge 57
Nyköping 53
Shanghai 49
The Dalles 46
Houston 44
Seattle 44
Hong Kong 43
Rome 39
Ho Chi Minh City 37
Cambridge 35
Hefei 35
Wilmington 34
Hanoi 30
Chicago 29
Lauterbourg 29
Munich 29
Ann Arbor 28
Istanbul 26
Buffalo 25
Milan 25
Boston 24
Columbus 23
Dong Ket 22
Seoul 20
Baghdad 18
Redwood City 18
North Bergen 17
Tokyo 17
Nuremberg 16
Orem 15
Phoenix 15
Toronto 15
Dearborn 14
Jacksonville 14
London 14
Denver 13
Madrid 12
Montreal 12
Redondo Beach 12
São Paulo 12
Brooklyn 11
Frankfurt am Main 11
Atlanta 10
Paris 10
Amsterdam 9
Salt Lake City 9
Tashkent 9
Elk Grove Village 8
San Diego 8
Selargius 8
Vienna 8
Da Nang 7
Dundalk 7
Düsseldorf 7
Haiphong 7
Lappeenranta 7
Mumbai 7
Nanjing 7
Santiago 7
Tampa 7
Warsaw 7
Belo Horizonte 6
Erbil 6
Hyderabad 6
Salvador 6
Shenzhen 6
Turku 6
Chennai 5
Dhaka 5
Mountain View 5
Naples 5
Sestu 5
Baku 4
Brno 4
Charlotte 4
Detroit 4
Dongguan 4
Florence 4
Giza 4
Guayaquil 4
Johannesburg 4
Lahore 4
Manchester 4
Mexico City 4
Miami 4
Totale 37.010
Nome #
Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet's Syndrome 3.202
Gene expression profiling of monozygotic twins affected by psoriatic arthritis 3.086
Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series 2.630
Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus 2.357
Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: An alternative to standard of care 2.294
Demyelinating syndrome in SLE encompasses different subtypes: Do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis 2.197
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study 1.679
Treatment target in newly diagnosed systemic lupus erythematosus: The association of lupus low disease activity state and remission with lower accrual of early damage 1.621
Use of Physician Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties 1.381
null 1.241
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis 1.228
Targeted Therapies in Axial Psoriatic Arthritis 1.205
Physician global assessment in systemic lupus erythematosus: Can we rely on its reliability? 1.153
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study 1.106
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 1.090
Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study 1.086
Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study 1.081
Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud's arthropathy and a distinctive MRI pattern 1.023
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review 949
Telemedicine in rheumatology: high specificity and sensitivity of follow-up virtual video consultations during COVID-19 pandemic 925
Patterns of Anti-Inflammatory and Immunomodulating Drug Usage and Microvascular Endothelial Function in Rheumatoid Arthritis 908
The Challenging Differentiation of Psoriatic Arthritis from Other Arthropathies and Nonspecific Arthralgias in Patients with Psoriasis: Results of a Cross-Sectional Rheumatologic Assessment of a Large Dermatologic Cohort 799
Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study 763
Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome 644
Treatment of psoriasis with different classes of biologics reduces the likelihood of peripheral and axial psoriatic arthritis development 591
Relevant domains and outcome measurement instruments in neuropsychiatric systemic lupus erythematosus: a systematic literature review 530
Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosus 519
Quality of Life in Systemic Lupus Erythematosus and Other Chronic Diseases: Highlighting the Amplified Impact of Depressive Episodes 364
Structural Brain MR Imaging Alterations in Patients with Systemic Lupus Erythematosus with and without Neuropsychiatric Events 276
Clinical patterns of disease: From early systemic lupus erythematosus to late-onset disease 272
Mood Disorder Questionnaire Positivity in Systemic Lupus Erythematosus and Other Chronic Diseases including Screen Bipolar Disorders or Rhythm and Energy Dysregulation Syndromes (DYMERS) 263
Stratifying patients by TNFSF13B genotype revealed increased flare and renal flare risk, but a greater benefit from belimumab: a potential biomarker for personalized treatment in systemic lupus erythematosus 213
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study 142
The metabolomic profile of psoriatic arthritis patients unveils the unbalance of disease-related molecules and pathways 90
Efficacy of Belimumab on Different Joint and Skin Manifestations of Systemic Lupus Erythematosus: Real-Life Data from a New Multicentric, Nationwide Italian Cohort (BeRLiSS-JS 2.0) 88
Ultrasound-Guided Synovial Biopsy Can Be Effectively and Safely Performed in Different Clinical Settings Favouring a Widespread Application of Precision Medicine in Rheumatoid Arthritis: A Post-hoc Analysis of Three Clinical Trials 83
Rationale for investigating the use of anifrolumab in neuropsychiatric systemic lupus erythematosus: a combined narrative and case-based systematic literature review 45
null 44
Machine Learning for MRI Classification of Systemic Lupus Erythematous Patients with and without Neuropsychiatric Events 12
Totale 39.180
Categoria #
all - tutte 55.653
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.653


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.877 0 0 0 76 150 107 137 139 192 263 450 363
2022/20233.547 363 503 387 268 260 442 198 251 232 238 259 146
2023/20246.327 108 178 215 456 550 673 590 2.199 243 224 457 434
2024/202513.031 4.007 4.241 1.249 1.139 566 606 652 56 114 116 166 119
2025/20263.396 212 222 365 222 257 225 635 253 305 334 269 97
2026/2027894 168 269 169 288 0 0 0 0 0 0 0 0
Totale 39.180